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Lineage dynamics of murine pancreatic
development at single-cell resolution
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Sarah M. Knox 3, Aaron D. Tward 4, Chun J. Ye 2 & Julie B. Sneddon 1
Organogenesis requires the complex interactions of multiple cell lineages that coordinate
their expansion, differentiation, and maturation over time. Here, we profile the cell types
within the epithelial and mesenchymal compartments of the murine pancreas across
developmental time using a combination of single-cell RNA sequencing, immuno-
fluorescence, in situ hybridization, and genetic lineage tracing. We identify previously
underappreciated cellular heterogeneity of the developing mesenchyme and reconstruct
potential lineage relationships among the pancreatic mesothelium and mesenchymal cell
types. Within the epithelium, we find a previously undescribed endocrine progenitor popu-
lation, as well as an analogous population in both human fetal tissue and human embryonic
stem cells differentiating toward a pancreatic beta cell fate. Further, we identify candidate
transcriptional regulators along the differentiation trajectory of this population toward the
alpha or beta cell lineages. This work establishes a roadmap of pancreatic development and
demonstrates the broad utility of this approach for understanding lineage dynamics in
developing organs.
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Pancreatic organogenesis is a complex and dynamic processthat ultimately results in the generation of multiple celllineages that perform the functions of the mature organ: the
regulation of glucose homeostasis by the endocrine compartment
and the production of digestive enzymes by the exocrine com-
partment. In the mouse, all known epithelial lineages of the
pancreas derive from a small field of epithelial precursor cells
within the foregut endoderm specified by the expression of
Pancreatic duodenal transcription factor 1 (Pdx1) (Fig. 1a)1. These
Pdx1+ cells evaginate into a cap of surrounding mesenchymal
cells around embryonic day 9 (E9), proliferate, and begin the
process of branching morphogenesis. Further epithelial lineage
diversification continues with the specification of Pdx1+ cells
into tip and trunk domains by E12 and progresses to the
restriction of tip cells to a digestive enzyme-producing acinar fate
and of trunk cells to either a ductal or endocrine cell fate1. Within
the trunk domain, induction of Neurogenin 3 (Ngn3) expression
defines the cells that will differentiate into one of five endocrine
lineages: alpha, beta, delta, gamma, or epsilon cells, marked by
expression of the hormones Glucagon (Gcg), Insulin (Ins),
Somatostatin (Sst), Pancreatic polypeptide (PP), or Ghrelin
(Ghrl), respectively2. Gastrin+ cells have also been recently
described3. Despite previous work focused on the formation of
the endocrine compartment, the precise timing and coordination
of lineage decisions are not completely understood.
Although the pancreatic mesenchyme is required for the
proper differentiation, proliferation, and morphogenesis of the
epithelial network1, little is known about the cell identities and
lineages that compose the pancreatic mesenchyme during devel-
opment. Even less is known about the mechanisms by which
these distinct mesenchymal cell types interact with one another
and with the cells of the epithelial compartment during devel-
opment and in the adult organ. Therefore, a deeper under-
standing of the full diversity of the mesenchymal cell types, as
well as their global gene-expression profiles, will serve as a basis
for understanding these key cellular interactions.
Recent studies of late embryonic, postnatal, and adult alpha
and beta cells have demonstrated the power of single-cell tran-
scriptomic profiling for unraveling endocrine lineage hetero-
geneity and revealing distinct transcriptional states of beta cell
maturation4–6. Here, we perform droplet-based, single-cell RNA
sequencing of entire murine embryonic pancreata at earlier
developmental timepoints to describe the cellular diversity and
dynamics of gene expression in both the epithelial and
mesenchymal compartments. We further identify and validate
these populations within mouse and human pancreatic tissue, as
well as human embryonic stem cell (hESC)-derived endocrine
progenitor cells. Finally, we predict lineage relationships, identify
previously unappreciated intermediate progenitor cells, and
validate our methodology using in vivo genetic lineage tracing.
Results
Cellular heterogeneity in the murine pancreas. We first char-
acterized the major sources of cellular heterogeneity in the
developing pancreas. Two batches of mouse pancreata at E14.5, a
particularly active time of expansion, morphogenesis, and diver-
sification2 (Fig. 1a), were dissected from individual litters, dis-
sociated into single-cell suspensions, sorted for live cells, and
sequenced using the 10x Chromium Single-Cell version 1 (v1)
kits (Fig. 1b and Supplementary Fig. 1a–e). We performed fil-
tering, normalization, variable gene identification, linear regres-
sion for batch, and principal component analysis (PCA) with the
R package Seurat (Supplementary Fig. 1d, e and 2a, b). Graph-
based clustering7 of batch-adjusted, merged data identified 19
distinct cell populations, classified as epithelial, mesenchymal,
immune, or vascular populations based on the expression of
known markers (Fig. 1c, d and Supplementary Data 1). We
identified expected populations, including endocrine, exocrine
(acinar and ductal), and endothelial cells (Fig. 1e). The propor-
tions of endocrine, mesenchymal, immune, and vascular popu-
lations were similar between E14.5 batches (Supplementary
Fig. 2b–d). Downsampling analysis confirmed that sufficient
sequencing depth had been reached for calling clusters (Supple-
mentary Fig. 2e–g). These results reveal the power of single-cell
RNA sequencing to identify a broad range of cell types during
development.
Characterization of mesenchymal heterogeneity. While pre-
vious studies have identified numerous markers of pancreatic
epithelial populations2, comparatively little is known about het-
erogeneity among pancreatic mesenchymal cells. We character-
ized the mesenchymal compartment by subclustering only
mesenchymal cells (5069 cells) and reperforming the clustering
analysis (Fig. 2a and Supplementary Fig. 3a). Despite being less
divergent from one another than were cells in the epithelial
compartment (Fig. 2b and Supplementary Fig. 3b), mesenchymal
cells could still be subdivided into ten transcriptionally distinct
mesenchymal clusters (Fig. 2a, c and Supplementary Data 2). We
verified the differential gene-expression analysis with three tests:
bimodal likelihood ratio test8, Wilcoxon rank sum, and MAST9
(Supplementary Fig. 3c and Supplementary Data 2). We anno-
tated two clusters based on the expression of known marker
genes: cluster 1 is pancreatic mesothelial cells (Wt1, Krt19, and
Upk3b)10,11 and cluster 3 represents vascular smooth muscle
(VSM) cells (Acta2, Tagln, and Myl9) (Fig. 2c and Supplementary
Data 2)12. Indeed, in E14.5 pancreas, Wt1 expression was
restricted to the tissue edge, as expected for mesothelial cells,
while Acta2 expression was localized to cells surrounding vessels,
as expected for VSM cells (Supplementary Fig. 3d, e). Cells in the
mesothelial cluster also expressed the secreted factors Fgf9, Pdgfc,
Rspo1, and Igfbp5 (Supplementary Fig. 3f) and genes regulating
prostaglandin hormone signaling and tight junctions (Fig. 2d and
Supplementary Data 3).
The remaining mesenchymal clusters included proliferating
cells (clusters 6–8), a large cluster (10) expressing pan-
mesenchymal markers, and four clusters (2, 4, 5, and 9) each
expressing a signature distinct from that of cluster 10 (Fig. 2a, c
and Supplementary Data 2). Cluster 2 was defined by differential
expression of Stathmin 2 (Stmn2), a gene involved in neurite
outgrowth and osteogenesis13,14. We also found two populations,
clusters 4 and 5, that differentially expressed multiple secreted
factors. Cluster 4 expressed Ace2, the chemokines Cxcl12 and
Cxcl13, and Vegfd, while cluster 5 expressed high levels of the
Wnt antagonists Secreted frizzled-related protein 1 and 2 (Sfrp1
and Sfrp2) (Fig. 2c–e and Supplementary Data 2). Cluster 5 also
expressed the transcription factor BarH-like homeobox1 1 (Barx1)
and members of the Id DNA-binding protein family (Fig. 2c–e
and Supplementary Data 2). Cluster 9 expressed Nk2 homeobox 5
(Nkx2-5) and Tlx1, transcription factors reported to contribute to
splenic development during a window in which the embryonic
pancreas and spleen share a mesenchymal compartment
(Fig. 2c)15. Pathway analysis identifies multiple signaling path-
ways that may be functionally relevant in these populations
(Fig. 2d and Supplementary Data 3). We validated a subset of
these distinct clusters using dual in situ hybridization/immuno-
fluorescence (ISH/IF) on E14.5 pancreas for differentially
expressed markers of clusters 1 (Cav1 and Barx1), 2 (Stmn2),
and 5 (Barx1) (Fig. 2e–h). These gene-expression profiles
demonstrate a previously underappreciated level of heterogeneity
in the mesenchymal compartment of the developing pancreas.
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Mesothelial cells undergo changes across developmental time.
During organogenesis, the dynamics of each lineage are defined
by the expansion, differentiation, and maturation of its con-
stituent cells. To address how these processes change across
chronological time within the developing pancreas, we performed
single-cell sequencing at two additional timepoints, E12.5 and
E17.5 (Fig. 3a). We identified mesenchymal cells from E12.5,
E14.5, and E17.5 timepoints, merged them into one dataset, and
reperformed the clustering analysis. We identified the clusters
detected in our E14.5 analysis (clusters 1–10) along with seven
new clusters (11–17) (Fig. 3a, Supplementary Fig. 3g–i, and
Supplementary Data 4). The addition of E12.5 and E17.5 cells
revealed further sub-division of the mesothelium into timepoint-
specific clusters (1, 11, and 17), each with unique transcriptomic
signatures (Fig. 3a, b). Within the mesothelium, we verified
Paired-like homeodomain transcription factor 2 (Pitx2) expression
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Fig. 1 Single-cell sequencing identifies broad patterns of cellular heterogeneity in E14.5 murine pancreas. a Overview of murine pancreatic development. b
Schematic of experimental approach. c t-Distributed stochastic neighbor embedding (t-SNE) visualization of populations from pooled E14.5 mouse
pancreata (n= 14). Each dot represents the transcriptome of a single cell, color-coded according to its cellular identity (epithelial, mesenchymal, or
immune/vascular). Each cell compartment contains multiple subpopulations, represented by varying degrees of color shading. d Established marker genes
identify epithelial cells (Cdh1+), endocrine cells (Chga+), mesenchymal cells (Vim+ and Col3a1+), endothelial cells (Pecam1+), and immune cells (Rac2
+). e Heatmap depicting greater than two-fold differentially expressed genes in each cluster compared to all other clusters. Cells are represented in
columns, and genes in rows. Specific genes used to annotate clusters are indicated to the right of the heatmap
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at E12.5 and its absence at E17.5 and Mesothelin (Msln) expres-
sion at E17.5 and its absence at E12.5 (Fig. 3c), consistent with the
single-cell data. These data provide evidence of transcriptional
maturation over developmental time within the mesothelial
compartment.
While the mesothelium is a well-established mesenchymal
progenitor cell population for VSM and fibroblasts in multiple
other organs, both the role of the mesothelium and the origin of
the mesenchymal cell types within the pancreas remain
uncharacterized16–19. We utilized our single-cell mesenchymal
dataset to determine whether the pancreatic mesothelium may
function as a mesenchymal progenitor cell population during
development. We found six populations (clusters 2, 3, 4, 5, 12,
and 13) that expressed VSM cell genes, such as Acta2 and Tagln,
or genes known to regulate VSM development, such as Mgp20,
Fhl121,22, Barx123, and Pitx224 (Fig. 3d). Based on these VSM-
related gene-expression profiles, we hypothesized that these
populations could represent VSM progenitors derived from the
pancreatic mesothelium. To test the lineage relationships among
these populations, we ordered cells in pseudotime based on their
transcriptional similarity25. This analysis placed mesothelial cells
on one side of the pseudotime trajectory (Fig. 3e). Mesothelial
branches corresponded to either a maturation process, based on
placement of E17.5 cells at the branch terminus, or proliferating
mesothelium, based on expression of proliferation genes (Fig. 3e
and Supplementary Fig. 3j). VSM-related populations were placed
on the other side of the trajectory (Fig. 3e and Supplementary
Fig. 3j). We calculated the proportion of each population over
pseudotime and found a transition from the E12.5 mesothelial
population (cluster 11) to cluster 12, both of which share
expression of the gene Pitx2 (Fig. 3e–g). Cluster 12 then
transitioned into the Stmn2-expressing cluster 2, which split into
a branch composed of VSM populations, clusters 3 and 13
(Branch 1), and a branch composed of clusters 4 and 5 (Branch 2)
(Fig. 3e–g). Thus, this analysis proposes clusters 2 and 12 as
potential mesothelial-derived mesenchymal progenitor popula-
tions that can contribute to the VSM lineages (Fig. 3g). Our
analysis has identified and validated multiple mesenchymal
subtypes and possible lineage relationships among them.
A previously undescribed endocrine progenitor population.
After assessing the heterogeneity within the mesenchymal com-
partment, we next focused on the epithelial cells. We first sub-
clustered the 2049 cells from our E14.5 dataset that comprised
just the epithelial populations (Fig. 4a and Supplementary
Fig. 4a). We identified 10 clusters, including acinar, ductal, beta,
alpha, and Ngn3+ progenitor populations, as revealed by dif-
ferential expression of known markers (Fig. 4a, b, Supplementary
Fig. 4b, and Supplementary Data 5). Our analysis highlighted
previously uncharacterized markers of acinar, Ngn3+, beta, and
alpha cell populations, such as Reep5, Btbd17, Gng12, and Peg10,
respectively (Fig. 4b and Supplementary Data 5). We also found
Sst- and Pancreatic polypeptide (Ppy)-expressing cells, but they
did not cluster into their own populations (Supplementary
Fig. 4c).
After the ductal, acinar, Ngn3+, and hormone+ populations
had been accounted for, there still remained one population that
eluded classification based on known marker genes. This
population was distinguished from all other epithelial populations
by high-level expression of the E26 transformation-specific
transcription factor Fev, previously shown to be expressed within
the developing pancreas but not described as a marker of a
distinct epithelial population26 (Fig. 4a, b and Supplementary
Data 5). This Fev+ population expressed genes marking
endocrine lineage cells, such as Paired box 4 (Pax4), chromo-
granins A/B (Chga/b) and Neurod11 (Supplementary Fig. 4d), but
not mature endocrine markers, such as Insulin1 (Ins1) or Gcg, or
the transitory early endocrine lineage marker, Ngn3 (Fig. 4b, c
and Supplementary Data 5). Pairwise comparison between the
Fev+ and Ngn3+ clusters identified 99 genes more highly
expressed in Fev+ and 87 more highly expressed in Ngn3+ cells,
suggesting that they are distinct populations (Fig. 4d). This Fev+,
Ngn3−, hormone− cluster will henceforth be referred to as the
FevHi population. Pathway analysis of the Ngn3+ and FevHi
populations revealed enrichment of cell cycle and Notch signaling
pathways in Ngn3+ cells (Fig. 4e and Supplementary Data 6),
likely reflecting the exit of Ngn3+ progenitors from the cell
cycle27 and the role of Ngn3 in Notch signaling28. The FevHi
cluster expressed genes in pathways related to serotonin, insulin,
Activating transcription factor 2 (Atf2), and sphingosine-1-
phosphate signaling, which have been reported to regulate
endocrine differentiation29,30. This relationship to serotonin is
consistent with prior work establishing Fev as a critical
transcription factor in serotonergic neurons26,31.
Further subclustering of all 661 cells within the endocrine
lineage revealed additional sub-groups of Fev-expressing cells.
The first was marked by high expression of Pax4 and Runx1
Translocation Partner 1 (Runx1t1) and lower levels of Ngn3. The
second was marked by Chgb and Vimentin (Vim) (Fig. 4f,
Supplementary Fig. 4e, f, and Supplementary Data 7). Therefore,
our analysis proposed the existence of multiple intermediate
states, marked by Fev, within the endocrine lineage. The Fev gene
was also expressed at lower levels in a subset of the hormone-
producing alpha, beta, and epsilon cell populations, which will
collectively be referred to as hormone+/FevLo populations
(Fig. 4b).
Given that the Fev+ populations expressed endocrine lineage
genes, we utilized pseudotime ordering25 to test the hypothesis
that both Fev+ populations were lineage-related to the Ngn3+
progenitors that give rise to the endocrine compartment of the
pancreas32. This de novo reconstruction of the developmental
trajectory placed both the Fev+/Pax4+ and FevHi/Chgb+ cells
between Ngn3+ endocrine progenitors and alpha and beta cells
(Fig. 4g and Supplementary Fig. 4g), suggesting that FevHi cells
comprise a progenitor stage following Ngn3 expression and before
hormone acquisition. The Fev+/Pax4+ population was placed
Fig. 2 Identification of multiple uncharacterized mesenchymal populations. a t-SNE visualization of subclustered E14.5 mesenchymal clusters (from n= 14
pancreata). b Density plot depicting Pearson’s correlation values (depicted in heatmap in Supplementary Fig. 3b) within the epithelial and mesenchymal
populations based on average gene expression in each cluster. c Dot plot of top differentially expressed markers of each mesenchymal population. Bars are
color-coded by cluster identity in a. The gray bar represents pan-mesenchymal markers. The size of each dot represents the proportion of cells within a
given population that expresses the gene; the intensity of color indicates the average level of expression. d Pathway analysis of genes greater than 2-fold
differentially expressed by cells in clusters 1, 2, 4, and 5. e Expression of genes marking clusters 1 (Cav1), 2 (Stmn2), 4 (Cxcl12), and 5 (Barx1) in all E14.5
mesenchymal cells. Color intensity indicates level of expression. f–hMultiplexed fluorescent ISH combined with Epcam IF validates clusters 2 and 5 (f) and
cluster 1 (g-h). Epcam marks pancreatic epithelium. In (f), Barx1+ cells (red arrows, cluster 5) are distinct from Stmn2+ cells (green arrows, cluster 2),
validating the single-cell data. In (g), Cav1+ cells (red arrows, cluster 1) are distinct from Stmn2+ cells (green arrows, cluster 2). In (h), Barx1+ cells that
do not express Cav1 (red arrows) represent cluster 5, whereas Barx1+/Cav1+ cells (yellow arrows) represent cluster 1. Cav1+ cells that do not express
Barx1 are also identified (green arrows), likely representing endothelial cells79. Scale bar represents 50 µm in f–h
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closer in pseudotime to the Ngn3+ population and was followed
by the FevHi/Chgb+ population (Fig. 4g), indicating that the
former represents an earlier cell state. Unlike alpha and beta cells,
epsilon cells were found throughout the trajectory populated by
the Fev+/Pax4+ and FevHi/Chgb+ populations (Fig. 4g),
possibly reflecting their function as multipotent progenitor cells
for alpha and gamma lineages during development33.
To validate these lineage relationships, we performed an in vivo
lineage trace of Ngn3+ cells. In E14.5 Ngn3-Cre; ROSA26mTmG
mouse pancreata, where lineage-traced cells are membrane-green
fluorescent protein (GFP+)34, approximately 20% of all Ngn3-
lineage-traced cells were identified as the FevHi population by the
presence of Fev and the absence of both Ngn3 and the pan-
differentiated endocrine cell marker Islet1 (Isl1) (Fig. 5a, e, yellow
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arrows and bar, and Supplementary Fig. 4h). We also detected the
hormone+/FevLo population identified by our single-cell data
(Fig. 5a, purple arrows) and cells that co-expressed Fev and Ngn3
(blue arrows), consistent with a model in which FevHi cells
represent an intermediate progenitor state following Ngn3+ cells,
but prior to differentiated endocrine cells (Fig. 5g).
We next tested if the FevHi population was also present in
developing human pancreatic tissue. In human fetal pancreas at
23 weeks postconception, we observed cells that expressed only
NGN3 (Fig. 5b, gray arrows), only CHGA (magenta arrows), a
marker of all hormone-expressing endocrine cells, and both FEV
and CHGA (purple arrows). We also detected cells that expressed
FEV but not NGN3 or CHGA (Fig. 5c, yellow arrows), analogous
to the murine FevHi population. The existence of these cellular
states in human development suggests that the lineage relation-
ships we identified generalize beyond murine pancreatic organo-
genesis to that of human, as well.
We then probed hESCs undergoing directed differentiation
toward the pancreatic beta cell lineage in vitro35. FEV was
detected in endocrine progenitor stage cells and beta-like cells
(BLCs) at levels comparable to adult human islets, but not in
undifferentiated hESCs (Supplementary Fig. 4i). Further, we
observed FEV+ (NGN3−/ISL1−) (yellow arrows), FEV+/ISL1+
(NGN3−) (purple arrows), and NGN3+/FEV+ (ISL1−) (blue
arrows) populations in differentiating hESC-derived cells midway
through the endocrine progenitor stage (Fig. 5d, f). While
endocrine differentiation progresses as a wave throughout
development36 in vivo, it is more synchronized in the hESC
differentiation platform in vitro35,37,38. At a timepoint directly
preceding beta cell differentiation, we found that nearly 70% of
hESC-derived cells were either NGN3+/FEV+ or FEV+ (Fig. 5f,
blue and yellow bars). These data place the FEV+ population at a
timepoint consistent with an endocrine progenitor population
during human beta cell differentiation in vitro.
Endocrine dynamics over developmental time. Although we had
captured comparatively fewer epithelial cells at E12.5 and E17.5
than at E14.5, we could still identify the FevHi cells at both time-
points (Supplementary Fig. 5a). To capture more epithelial cells and
account for those that were missing from E12.5 and E17.5 version 1
(v1) runs, we reperformed an entirely new (version 2) set of single-
cell RNA-sequencing experiments at E12.5, E14.5, and E17.5 after
depletion of CD140a+ mesenchymal cells in order to enrich for
epithelial cells (Supplementary Fig. 5b, c). Given the high numbers
of red blood cells at E17.5, we ran two wells of E17.5 cells (replicates
1 and 2) to increase our capture of epithelial cells and then
aggregated the datasets. We first analyzed the exocrine compart-
ment and identified acinar, ductal, and proliferating populations of
both at all timepoints (Supplementary Fig. 5d and Supplementary
Data 8–10). We then focused on the endocrine compartment,
where we captured 584, 1267, and 1837 endocrine cells at E12.5,
E14.5, and E17.5, respectively. We found similar gene-expression
topologies as in our v1 dataset but gained additional resolution with
increased cell numbers and transcriptomic coverage (Supplemen-
tary Fig. 5e and Supplementary Data 11–13).
To analyze how endocrine populations change over time, we
merged all three v2 timepoints into one dataset using canonical
correlation analysis39. We correlated the v2 dataset to the v1
dataset and could identify all populations present in the v1
dataset (Supplementary Fig. 5f and Supplementary Data 14). We
also found additional populations, including a cluster character-
ized by decreased expression of Fev and increased expression of
Pdx1 and Mafb, genes with known roles in endocrine lineage
decisions (Fig. 5h and Supplementary Fig. 5g). This Pdx1+/Mafb+
population correlates most strongly with the FevHi/Chgb+
population, as well as both the alpha and beta cell populations
in the v1 dataset (Supplementary Fig. 5f). We also found a second
beta cell population characterized by increasing expression of Ins1
and Ins2 and lower expression of Pdx1, perhaps representing
more mature beta cells (Supplementary Fig. 5g). Indeed, this
second beta cell group is almost entirely comprised of cells from
the E17.5 timepoint (Fig. 5i). To examine how these populations
shift over developmental time, we calculated the proportion of
these populations at each timepoint (Fig. 5j). We found shifts in
cell proportions that match those reported in literature, such as a
high proportion of alpha cells early in development at E12.5 and
increasing proportions of beta and delta cells at later time-
points36. The Ngn3+ population decreased over time, while the
Fev+/Pax4+, FevHi/Chgb+, and Pdx1+/Mafb+ populations
peaked at E14.5, consistent with previous studies that reported
peak Ngn3 expression at approximately E14.5 and its subsequent
downregulation as differentiation into endocrine lineage ensues40.
At E17.5, we also found an increasing proportion of proliferating
endocrine cells, presumably those responsible for the expansion
of endocrine cell mass in later embryonic development41. These
results from the larger v2 dataset confirm our initial findings from
the v1 dataset and add additional resolution to the endocrine
populations during pancreatic development.
Lineage decisions within the endocrine compartment. As the
in vivo lineage tracing data had revealed that the FevHi popula-
tion is derived from the Ngn3+ population, we hypothesized that
the FevHi population could then function as a progenitor for the
endocrine populations of the developing pancreas. We utilized a
Fev-Cre; ROSA26mTmG lineage tracing strategy to label Fev-
expressing cells and their progeny. We found that 100% of alpha,
beta, and delta cells, 90.1% of gamma cells, and 23.2% of epsilon
cells were lineage-traced in E14.5 pancreas (Fig. 6a–e). These
proportions of lineage labeling held true later in development
(E17.5) and in adulthood (6 weeks) (Supplementary Fig. 6 and 7).
Epsilon cells are rare in the adult pancreas33 and still exhibited
only partial lineage tracing in E17.5 pancreas (47.8% traced)
(Supplementary Fig. 6e). These results demonstrate that the
Fig. 3Mesothelial cells are dynamic over developmental time and are predicted to give rise to vascular smooth muscle populations. a t-SNE visualization of
merged mesenchymal clusters from E12.5 (n= 18 pancreata), E14.5 (n= 14 pancreata for batch 1; n= 11 for batch 2), and E17.5 (n= 8 pancreata) tissue.
Mesenchymal clusters were identified at each timepoint, subclustered, merged together, and reanalyzed. Cells are colored by cluster or timepoint. Dotted
circle highlights timepoint-segregated mesothelial clusters. b Dot plot of top differentially expressed genes in timepoint-specific mesothelial clusters
(clusters 1, 11, and 17). Size of the dot represents proportion of the population that expresses each specified marker. Color indicates level of expression. c
ISH for Pitx2 andMsln in E12.5 and E17.5 pancreata. Pitx2 expression was detected in E12.5, but not E17.5 mesothelium, whereasMsln was detected in E17.5,
but not E12.5 mesothelium. Vimentin (Vim) IF staining depicts pancreatic mesenchyme. Dotted line indicates tissue boundary. Yellow arrows identify Pitx2
+ mesothelial cells. Red arrows identify Msln+ mesothelial cells. Scale bar represents 50 µm. d Expression levels of VSM-related genes in merged
mesenchymal clusters. Color intensity indicates level of expression. e Pseudotime ordering of mesothelial and VSM-related merged mesenchymal clusters.
Colors correspond to t-SNE in a. All clusters are individually plotted in Supplementary Fig. 3j. f Cluster proportions over pseudotime. Pseudotime was
binned into ten groups and the proportion of each cluster within that bin of pseudotime was calculated. gModel of lineage relationships among mesothelial
and VSM-related mesenchymal populations based on pseudotime ordering in e
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majority of endocrine cells pass through a Fev-expressing stage
during development.
We next combined this lineage tracing approach with single-
cell RNA sequencing to identify transcriptional regulators of
endocrine differentiation. FACS sorting was used to enrich for
Fev-expressing cells and their progeny (membrane GFP+) from
Fev-Cre; ROSA26mTmG pancreata at E14.5 (Fig. 6f, g). All
expected endocrine populations were identified in the resulting
single-cell dataset (Fig. 6h, i). In addition, we found that eGFP
reads mapped to all endocrine populations except the Ngn3+
population (Fig. 6i), further confirming that Fev expression turns
on after Ngn3.
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We next set out to model the lineage relationships among the
endocrine cells and identify transcriptional regulators of differ-
entiation. Pseudotime ordering identified a trajectory that began
with Ngn3+ cells, transitioned into Fev+ cells, and then split into
two main branches (Fig. 7a; see similar branching pattern in
analysis of our first v1 dataset, Supplementary Fig. 8a). The
termini of the branches were populated by differentiated beta and
alpha cells, suggesting that the branches represent a transition
from a progenitor to fully differentiated hormone+ cell (Fig. 7a).
We next used Monocle’s branched expression analysis
modeling (BEAM) to identify the genes that distinguish the
paths along the two branches to either alpha or beta cells. We
found gene clusters that were upregulated along different
segments of the pseudotime trajectory (Fig. 7b and Supplemen-
tary Data 15) and performed pathway analysis to identify
pathways enriched at each stage of pseudotime (Supplementary
Fig. 8c and Supplementary Data 16). Genes upregulated at the
beginning of pseudotime in gene cluster 2, included early markers
of endocrine differentiation, such as Sox4 and Ngn3 (Fig. 7b). Fev
was in gene cluster 6 and increased in both branches before
ultimately decreasing in expression at the branch termini (Fig. 7b,
c). Gene cluster 6 also included other genes expressed within the
FevHi population, including Cldn4, Vim, and Chgb (Fig. 7b, c and
Supplementary Fig. 8b). We found branch-specific clusters that
included known markers of beta (Ins1) and alpha (Gcg) cells and
known differentiation regulators of alpha (Arx, Pou3f4, Irx1,
Slc38a5, and Tmem27) and beta (Pdx1, Pak3, and Nkx6-1) cells
(Fig. 7c and Supplementary Fig. 8b)2,42–45. These clusters also
contained genes that were enriched in either the alpha or beta
branch but were expressed before acquisition of hormone
expression (Supplementary Fig. 8b). Within the alpha cell branch,
Peg10, Smarca1, Auts2, and Wnk3 increased in expression before
upregulation of Gcg occurred (Supplementary Fig. 8b). Peg10 and
Auts2 have roles in differentiation46,47 and migration48, but a role
in endocrine differentiation has not been described. As a
regulator of chromatin states and an adult human alpha cell
marker49, Smarca1 may be involved in the epigenetic regulation
of alpha cell differentiation. Within the beta cell branch, Gng12,
Tssc4, Ece1, Tmem108, Wipi1, and Papss2 increased in expression
before upregulation of Ins1 (Supplementary Fig. 8b). To our
knowledge, a role in endocrine lineage decisions have not been
described for these beta branch-specific genes. We found a similar
endocrine differentiation trajectory by an orthogonal method that
uses force-directed layouts to visualize gene topologies and infer
lineage relationships within single-cell data50,51 (Supplementary
Fig. 8d). We hypothesize that the genes identified by the analysis
above may represent regulators of the differentiation of an
endocrine progenitor to a fully differentiated hormone-expressing
cell.
To validate our pseudotime results, we performed ISH for
markers that defined each branch of the trajectory. First, we
confirmed the expression of Peg10 and Gng12 within the FevHi
population (Fig. 7d, e, indigo and teal gradient arrows), validating
the expression of these genes in a stage before hormone
acquisition. We also validated the enrichment of Peg10 and
Gng12 in alpha and beta cells, respectively (Fig. 7f, g, solid indigo
and teal arrows). First, 95.8% of beta cells expressed Gng12 (n=
46 cells, 6 pancreata), while 30.5% expressed Peg10 (n= 71 cells, 7
pancreata) (Fig. 7f and Supplementary Fig. 9a). Additionally,
100% of alpha cells expressed Peg10 (n= 31 cells, 6 pancreata),
while only 5.4% expressed Gng12 (n= 32 cells, 4 pancreata)
(Fig. 7g and Supplementary Fig. 9b). The lineage relationships
generated by pseudotime ordering, combined with the validation
in vivo, lead us to hypothesize that the Fev+/Peg10+ cells are
fated toward an alpha cell identity and Fev+/Gng12+ cells
toward a beta cell identity (Fig. 7h). These results suggest that
lineage allocation of endocrine progenitors toward alpha or beta
cell fates may occur after the onset of Fev expression.
Discussion
The mesenchyme is critical for epithelial specification and pro-
liferation throughout pancreatic development52–54, yet the indi-
vidual cell types responsible for these processes remain
unidentified. Our single-cell dataset has enabled the identification
of multiple mesenchymal subpopulations and gene candidates for
regulating epithelial–mesenchymal interactions. Secreted factors,
such as mesothelial-derived Fgf9, may play a similar role in the
pancreas as in the lung, where it regulates mesenchymal cell
proliferation and vascular formation55. Additionally, secretion of
Wnt antagonists by cluster 5 may regulate Wnt signaling in the
developing pancreas, influencing processes such as epithelial
specification, expansion, and exocrine development56. Future
work can focus on uncovering the functions of these individual
mesenchymal populations in the development, physiology, and
pathology of the pancreas.
With the cell types of the mesenchyme now enumerated and
their markers identified, we can begin to elucidate the maturation
and lineage relationships of the pancreatic mesenchymal compart-
ment. Our time-course data have provided evidence of maturation
within the mesothelial population. Genes such as Pitx2, kallikren 13
(Klk13) and 8 (Klk8), were differentially expressed in younger, E12.5
mesothelial cells. Pitx2 regulates differentiation in multiple
systems24,57,58, and the kallikren family are serine proteases
involved in the degradation of extracellular matrix and adhesion
molecules59. Expression of these genes suggests that the E12.5
mesothelial population may be primed for migration and differ-
entiation. In contrast, the E17.5 mesothelial population expressed
genes related to barrier or immune function, such as dermokine
(Dmkn)60,61, bone marrow stromal antigen 2 (Bst2), and retinoic
acid receptor responder 2 (Rarres2)62. These results suggest stage-
dependent roles for the mesothelium throughout development.
The different roles for the mesothelium across time are also
evident from our pseudotime analysis, which proposes that the
mesothelium serves as a progenitor for other mesenchymal cell
types during development. The mesothelium is a critical
mesenchymal progenitor population in other organs, such as the
heart, intestine, lung, and liver16–19. Our data suggest that
mesothelial progenitor activity occurs at E12.5 or earlier during
pancreatic development, consistent with other organ
systems11,16,18. Indeed, a recent study identified that parietal
mesothelial cells can function as progenitor cells prior to pan-
creatic specification63. The transcriptomic information obtained
Fig. 4 Identification of epithelial cell populations in E14.5 mouse pancreas. a t-SNE visualization of epithelial groups only, as defined in Fig. 1. b Dot plot
depicting known and uncharacterized markers of epithelial populations, as well as markers specific to the FevHi population. Size of the dot represents
proportion of the population that expresses each specified marker. Color indicates level of expression. c Expression of Fev and Ngn3 within epithelial cells.
Color indicates level of expression. d Gene expression comparison between the Ngn3+ and FevHi population. Genes greater than 2-fold differentially
expressed are highlighted in dark blue (higher in FevHi cells) or light blue (higher in Ngn3+ cells). e Pathway analysis of genes greater than 2-fold
differentially expressed in Ngn3+ and FevHi populations. f t-SNE visualization of the 661 cells of the endocrine lineage (Ngn3+, FevHi, alpha, beta, and
epsilon populations). g Pseudotime ordering of Ngn3+, Fev+/Pax4+, FevHi, alpha, and beta cell populations place Fev+ cells between Ngn3+ and
hormone+ populations
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by this study will allow the development of tools to target indi-
vidual populations within the mesenchyme and perform lineage
tracing, ablation, and expression studies in vivo. Furthermore,
this developmental dataset can be compared to mesenchymal
population dynamics during adult disease progression, where
aberrant recapitulation of developmental pathways can lead to
disease states in the pancreas64,65. Thus, this dataset is a broad
resource for the implementation of future studies in pancreatic
mesenchymal biology.
Within the epithelial compartment, our identification of a
FevHi endocrine progenitor population provides increased reso-
lution of endocrine differentiation. The relative timing of
expression of canonical endocrine lineage genes can now be
mapped onto these additional differentiation stages. Several lines
of evidence suggest that the gene Fev may be a direct target of
Ngn3: Fev is the transcription factor most strongly expressed in
Ngn3+ endocrine progenitors66, and Ngn3 knockout embryos do
not express Fev in the developing pancreas26. Known target genes
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of Ngn3, such as Pax467 and Runx1t168, are expressed by the
early-stage Fev+/Pax4+ population. Additionally, Pax6 is upre-
gulated within the FevHi population. Although Chga and Chgb are
often utilized as markers of differentiated endocrine lineages, we
found that both are expressed in the FevHi population prior to
hormone acquisition. This result is consistent with previous work
that identified Chga+, hormone– cells in rodent pancreatic
development69. The FevHi cell stage likely represents the cell stage
during endocrine differentiation preceding specialized hormone
production and may now serve as a cellular landmark for
understanding endocrine lineage gene-expression dynamics.
The gene Fev has been previously studied mainly in ser-
otonergic neurons, where it is a master transcriptional regulator
required for cellular differentiation, maturation, and serotonin
synthesis31. Fev switches transcriptional targets from differ-
entiation genes during development to maturation genes post-
natally in serotonergic neurons70. In an insulinoma cell line, Fev
directly binds to the regulatory regions of serotonergic genes,
such as Tph1, Tph2, Ddc, Slc18a2, and Slc6a4, as well as the Ins1
promoter itself26. Future ChIP-seq studies of embryonic pancreas
will globally identify direct targets of Fev and Fev-regulated
transcriptional networks in developing endocrine cells.
Using genetic lineage tracing in vivo, we have demonstrated
that the majority of endocrine cells in the developing pancreas
transit through a Fev-expressing stage, and that Fev-lineage cells
contribute not only to embryonic, but also to adult pancreatic
endocrine cells. The fraction of epsilon cells not derived from a
Fev-lineage may represent the subset of Ghrl+ cells previously
reported to give rise to the ductal and exocrine lineages33. As all
adult gamma cells are Fev-lineage labeled, the small subset of
gamma cells not lineage traced during pancreatic development
may represent those that do not persist in the adult pancreas.
Further highlighting the relevance of FevHi progenitors during
pancreatic development, our pseudotime analysis revealed that
Fev-expressing cells may be pre-specified towards an alpha or
beta cell fate. As expected, we found expression of Ins1 and Gcg at
the termini of the beta and alpha branches, and upregulation of
Pdx1 and Arx, which are known regulators of endocrine cell fate
decisions, earlier in pseudotime. In addition, our pseudotime
analysis identified genes enriched along the alpha or beta branch
and expressed prior to upregulation of hormones. These genes
warrant further study as potential regulators of the acquisition of
alpha or beta cell identity.
For the eventual application of this knowledge to human
therapeutics, the findings in the murine model must be validated
in human pancreatic development. Our staining of human fetal
pancreas identified the analogous FEVHi population, consistent
with our findings in murine pancreata. Directed differentiation of
hESCs toward endocrine cell fates will provide a platform for
modeling and manipulating the putative lineage regulators found
in this study. Indeed, we have identified a FEV+ population
within hESC-derived endocrine progenitor cells. Deeper knowl-
edge of these lineage decisions may substantially improve directed
differentiation efforts to efficiently generate functional beta cells
for cellular replacement therapy for people with diabetes. This
study highlights the power of combining single-cell tran-
scriptomic information with in vivo lineage tracing to reconstruct
developmental trajectories within cellular compartments. Dis-
covery of populations and their lineage relationships will promote
identification of the mechanisms that drive lineage decisions and
commitment.
Methods
Mice. All mouse procedures were approved by the University of California, San
Francisco (UCSF) Institutional Animal Care and Use Committee. Mice were
housed in a 12-h light-dark cycle in a controlled temperature climate. Noon of the
day of vaginal plug was considered embryonic day 0.5.
Timed-pregnant Swiss Webster mice were obtained from Charles River
Laboratories. Ngn3-Cre71 (a gift from Dr. Matthias Hebrok), Fev-Cre72 (The
Jackson Laboratory 012712), and ROSA26mTmG 34 (the Jackson Laboratory 007676)
mice were maintained on a C57BL/6J background. The Cre transgene was
genotyped using the following primers: GGGCGGCATGGTGCAAGTT and
CGGTGCTAACCAGCGTTTTC.
Human tissue procurement and isolation. Human fetal pancreata were harvested
from post-mortem fetuses at 23 weeks of gestation with permission from the ethical
committee of UCSF. Tissue was fixed in 4% paraformaldehyde overnight at
4 °C. After three washes in 1X phosphate-buffered saline (PBS), tissue was either
cryopreserved in 30% sucrose solution at 4 °C overnight and embedded in optimal
cutting temperature (OCT) compound, or placed in 40% ethanol then 70% ethanol
before paraffin embedding. Sections measuring 8 µm were cut on the cryostat or
microtome. In situ hybridization and immunofluorescence were then performed as
described below.
Adult human islets were isolated from cadaveric donor tissue by the UCSF Islet
Production Core with permission from the UCSF ethical committee. Consented
cadaver donor pancreata were provided by the nationally recognized organization
UNOS via local organ procurement agencies. The identifiers were maintained at
the source only, and the investigators received de-identified specimens.
Informed consent was obtained for all human (fetal and adult) tissue collection,
and protocols were approved by the Human Research Protection Program
Committee on Human Research of UCSF.
Embryonic stem cell culture and differentiation. The hESC line HUES8 was
obtained from Harvard University and used for the generation of hESC-derived
BLCs. Pluripotent HUES8 cells were maintained as spherical clusters in suspension
in mTeSR-1 (StemCell Technologies) in 500 mL spinner flasks (Corning, VWR) on
a magnetic stir plate (Dura-Mag) within a 37 °C incubator at 5% CO2, 100%
humidity, and a rotation rate of 70 rpm. Cells were screened for mycoplasma
contamination using the MycoProbe Mycoplasma Detection Kit (R&D Systems),
according to the manufacturer’s instructions.
hESC-derived endocrine progenitor cells were generated as previously
described35. In brief, HUES8 cells were seeded into a spinner flask at a
Fig. 5 FevHi cells are endocrine progenitors. a In situ hybridization (ISH) for Ngn3, Fev, and Isl1 in lineage-traced Ngn3-Cre; Rosa26mTmG E14.5 pancreata
where Ngn3-lineage-traced cells are mGFP+. Gray arrowheads identify Ngn3+ cells, presumably not yet Ngn3-lineage labeled due to the transient nature
of Ngn3 expression and the delay of Cre-mediated recombination that permits expression of mGFP. Blue arrowheads identify Ngn3+/Fev+ cells that are
Ngn3-lineage-traced. Yellow arrowheads identify Ngn3-lineage-traced cells that are Fev+, but do not express Ngn3 or Isl1. Purple arrowheads identify Fev
+/Isl1+ cells that are Ngn3-lineage-traced. Magenta arrowheads identify Isl1+ cells that are Ngn3-lineage-traced. b–c Dual ISH/immunofluorescence (IF)
for NGN3 and FEV mRNA and CHGA protein in human fetal pancreas at 23 weeks of gestation (n= 1 pancreas). Gray arrowheads identify NGN3+ cells.
Yellow arrowheads identify FEV+ cells. Purple arrowheads identify FEV+/CHGA+ cells. Magenta arrowheads identify CHGA+ cells. d Multiplexed
fluorescent ISH for NGN3, FEV, and ISL1 mRNA in hESC-derived endocrine progenitor cells. Blue arrowheads identify NGN3+/FEV+ cells. Yellow
arrowheads identify FEV+ cells. Purple arrowheads identify FEV+/ISL1+ cells. e Quantification of each population detected in Ngn3-lineage-traced
pancreata as a percentage of Ngn3-lineage-traced cells (n= 464 cells, 6 pancreata). Data are represented as mean+ standard deviation (SD). f
Quantification of each population detected in hESC-derived progenitor cells as a percentage of total stained cells (n= 418 cells, 3 clusters representing
technical replicates from one hESC differentiation). Data are represented as mean+ SD. g Proposed model for the derivation of FevHi endocrine cells from
Ngn3+ cells, and their differentiation into hormone+/FevLo endocrine cells. Colors of arrowheads and bars in a–f correspond to cell identity in g. a, d Scale
bar: 10 µm. b, c Scale bar: 20 µm. h t-SNE visualization of v2 merged endocrine timecourse (E12.5, E14.5, aggregated E17.5). Clusters are annotated based
on correlation with v1 dataset or top differentially expressed genes. i Timepoint labels for v2 merged endocrine timecourse data. t-SNE is the same as h. j
Cell type proportions at each timepoint, calculated from the clusters depicted in h
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concentration of 8 × 105 cells/mL in mTeSR-1 media with 10 μM Rock inhibitor
Y27632 (StemCell Technologies) to allow formation of spherical clusters.
Differentiation was initiated 72 h later. Differentiation was achieved in a step-wise
fashion using the following growth factors and/or small molecules: definitive
endoderm (Stage 1) (1 day of 100 ng/mL Activin A (R&D Systems) and 14 μg/mL
of CHIR99021 (Stemgent); 2 days of 100 ng/mL Activin A); gut tube endoderm
(Stage 2) (3 days of 50 ng/mL KGF (Peprotech)); early pancreatic progenitors
(Stage 3) (1 day of 200 nM LDN193189 (Fisher Scientific), 50 ng/mL KGF, 0.25 μM
Sant-1 (Sigma), 2 μM Retinoic Acid (Sigma), 500 nM PdbU (EMD Biosciences); 1
day of 50 ng/mL KGF, 0.25 μM Sant-1, 2 μM Retinoic Acid, 500 nM PdbU); later
pancreatic progenitors (Stage 4) (5 days of 50 ng/mL KGF, 0.25 μM Sant-1, 0.1 μM
Retinoic Acid); endocrine progenitors (Stage 5) (4 days of 0.25 μM Sant-1, 0.1 μM
Retinoic Acid, 1 μM XXI (EMD Millipore), 10 μM Alk5i (Axxora), 1 μM T3 (EMD
Biosciences), 20 ng/mL Betacellulin (Fisher Scientific); 3 days of 25 nM Retinoic
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Acid, 1 μM XXI, 10 μM Alk5i, 1 μM T3, 20 ng/mL Betacellulin); BLCs (Stage 6)
(6 days of 10 μM Alk5i; 1 μM T3). Successful differentiation was assessed at Stages
1, 3, 4, 5, and 6 via immunofluorescence or FACS for stage-specific marker genes.
To measure the expression of FEV at various stages of human endocrine
differentiation, aliquots of clusters were removed from the flask and analyzed at
several timepoints: after 5 days in Stage 5 (“mid-stage endocrine progenitors”),
after 7 days in Stage 5 (“late-stage endocrine progenitors”), and after 5 days at the
BLC stage. As a comparator, pluripotent, undifferentiated hESCs in mTeSR-1, as
well as human adult islets, were also analyzed for FEV expression.
Immunofluorescence. Embryonic mouse pancreata were dissected in cold 1X PBS
and fixed in zinc-buffered formalin (Anatech LTD) at room temperature (RT) for
30–90 min or overnight at 4 °C. After three washes in 1X PBS, tissue was processed
for either cryopreservation or paraffin embedding. Cryopreserved pancreata were
placed in 30% sucrose solution at 4 °C overnight before embedding in OCT.
Paraffin-embedded pancreata were placed in 40% ethanol and 70% ethanol before
paraffin tissue processing. Sections measuring 8 µm sections were cut on the
cryostat or microtome. For immunofluorescence on paraffin sections, slides were
baked at 55 °C for 30 min, deparaffinized in xylene, and rehydrated in decreasing
concentrations of ethanol. Heat-mediated antigen retrieval was performed using
Antigen Retrieval Citra Solution (Biogenex Laboratories). Tissue sections were
blocked in 5% normal donkey serum (NDS; Rockland Immunochemicals) and
Mouse-on-Mouse IgG blocking reagent (Vector Laboratories) when appropriate in
0.2% Triton X-100 in PBS (PBT) for 1 h and then stained overnight at 4 °C using
the following primary antibodies: Acta2 (1:200, Abcam ab21027), Cav1 (1:200,
Abcam ab2910), Chromogranin A (1:100, Abcam ab15160), E-cadherin (1:200, BD
Transduction Lab 610182), Glucagon (1:100, Abcam ab82270), Insulin (1:50,
DAKO A0564), Vimentin (1:200, Abcam ab92547), and Wt1 (1:100, Abcam
ab89901). All antibodies have been validated by the manufacturer. The next day,
sections were washed three times in 0.1% Tween 20 in 1X PBS and then incubated
with species-specific Alexa Fluor 488-, 594-, or 647-conjugated secondary anti-
bodies (1:500, Jackson ImmunoResearch) and DAPI in 5% NDS in 0.2% PBT for 1
h at RT. Sections were washed three times in 0.1% Tween 20 in 1X PBS, rinsed in
1X PBS, and then mounted in Fluoromount-G mounting medium (South-
ernBiotech). Slides were stored at 4 °C.
For immunofluorescence on cryosections, slides were removed from −80 °C
storage and allowed to reach RT. Sections were rinsed in 1X PBS three times and
permeabilized in 0.5% PBT for 10 min at RT. Tissue sections were blocked in 5%
NDS and, if needed, Mouse-on-Mouse IgG blocking reagent in 0.1% PBT for 1 h
and then stained overnight at 4 °C using the following primary antibodies: Epcam
(1:200, BD Transduction Lab 552370), Glucagon (1:2000, Millipore 4031-01F),
Insulin (1:250, DAKO A0564), Somatostatin (1:500, Santa Cruz Biotechnology) sc-
7819, Ghrelin (1:1500, Santa Cruz Biotechnology sc-10368), Pancreatic Polypeptide
(PP; 1:250, Abcam ab77192), and Vimentin (1:200, Abcam ab92547). All
antibodies have been validated by manufacturer. Sections were washed the next day
three times in 1X PBS and then incubated with species-specific Alexa Fluor 488-,
555-, 594-, or 647-conjugated secondary antibodies and DAPI in 5% NDS in 0.1%
PBT for 1 h at RT. Sections were washed three times in 1X PBS and mounted in
Fluoromount-G mounting medium. Slides were stored at 4 °C.
Images were captured on a Zeiss Apotome Widefield microscope with optical
sectioning capabilities or Leica confocal laser scanning SP8 microscope. Maximum
intensity z-projections were then prepared using ImageJ, where brightness,
contrast, and pseudo-coloring adjustments were applied equally across all images
in a given series.
In situ hybridization. In situ hybridization was performed on 8 µm sections using
RNAscope technology (Advanced Cell Diagnostics)73 according to the manu-
facturer’s instructions. In situ probes against mouse Ngn3 (422409-C2), Fev
(413241-C3), Isl1 (451931), Ins1 (414661-C4), Gcg (400601), Sst (404631-C3), Ghrl
(415301-C2), Ppy (482701), Peg10 (512921-C4), Gng12 (462521-C2), Nnat
(432631-C2), Barx1 (414681), Pitx2 (412841-C2), Stmn2 (498391-C3), Msln
(443241) and human NGN3 (505791-C4), FEV (471421-C3), and ISL1 (478591-
C2) were used in combination with the RNAscope Multiplex Fluorescent Reagent
Kit v2 for target detection. Following signal amplification of the target probes,
sections were washed in 1X PBS three times and blocked in 5% NDS in 0.1% PBT
for 1 h at RT. Tissue sections were then stained with primary and secondary
antibodies as described above in the “immunofluorescence” section.
For in situ hybridization of hESC-derived clusters, cells were fixed with 4% PFA
for 15 min at RT, washed with PBS, and cryoprotected in 30% sucrose overnight.
The next day, clusters were embedded in a small sphere of 1.5% low-melting
temperature agarose; these were again cryoprotected in 30% sucrose overnight. The
following day, the agarose spheres were soaked in OCT and frozen in a dry ice
bath. In situ hybridization was then performed on 8 µm sections using human
NGN3, FEV, and ISL1 RNAscope probes.
Quantification of cell proportions. Quantification of pancreata was performed by
manual counting using ImageJ software. Cell populations present at less than 1% in
Ngn3-lineage-traced E14.5 replicates were deemed artifact and excluded from
further analysis.
Quantitative RT-PCR. hESCs from various stages of directed differentiation were
collected and RNA was extracted with the RNeasy Mini Kit (Qiagen). Reverse
transcription was performed with the Clontech RT-PCR kit. RT-PCR was run on a
7900HT Fast RT-PCR instrument (Applied Biosystems) with Taqman probes for
FEV (assay ID: Hs00232733_m1) and GAPDH (assay ID: Hs02758991_g1) in
triplicate. Data were normalized to GAPDH. Error bars represent standard
deviation.
Dissociation and FACS of embryonic pancreas. Embryonic mouse pancreata
were dissected and placed in 1X PBS on ice, then dissociated into single cells using
TrypLE Express dissociation reagent (Thermo Fisher) at 37 °C with pipet tritura-
tion at 5-min intervals during incubation. For v1 datasets, E12.5 pancreata were
dissociated for 10 min, E14.5 pancreata for 15 min, and E17.5 pancreata for 30 min.
For batch 1, we pooled 14 E14.5 pancreata from one litter. For batch 2, which was
collected on a different day, we pooled tissue from each timepoint separately: 18
E12.5 pancreata from two litters, 11 E14.5 pancreata from one litter, and 8 E17.5
pancreata from one litter. Dissociations were neutralized with FACS buffer (10%
FBS+ 2 mM EDTA in phenol-red free HBSS). Dissociated cells were passed
through a 30 µm cell strainer and stained with Sytox live/dead stain (Thermo
Fisher). Stained cells were washed twice in FACS buffer and then sorted using a BD
FACS Aria II. After size selection to remove doublets, all live cells were collected.
For v2 10X datasets, we pooled tissue from each time point separately, each
performed on a different day: 14 E12.5 pancreata from one litter, 13 E14.5
pancreata from one litter, and 13 E17.5 pancreata from one litter. For the E14.5
Fev-Cre; ROSA26mTmG 10X sample, we pooled three pancreata from one litter.
Dissociations were performed as described above. Cells undergoing a CD140a
negative selection were stained with CD140a-APC (1:50; eBiosciences, cat. 17-
1401-81; validated by manufacturer). Stained cells were washed twice in FACS
buffer and then sorted using a BD FACS Aria II. After size selection to remove
doublets, all live CD140a− cells were collected. For the E14.5 Fev-Cre; mTmG
pancreata, live GFP+ cells and GFP−/TdTomato+ cells were collected. All 4000
GFP+ (Fev-lineage traced) cells were loaded onto the 10X Genomics platform,
supplemented with an additional 21,000 TdTomato+/GFP− (non-lineage traced).
Single-cell capture and sequencing. To capture individual cells, we utilized the
Chromium Single Cell 3' Reagent Version 1 Kit (10X Genomics)74. For batch 1,
12,800 cells from E14.5 pancreata were loaded into one well of the 10X chip, while
for batch 2, 18,000 cells per time point were each loaded into their own respective
wells to produce Gel Bead-in-Emulsions (GEMs). GEMs underwent reverse tran-
scription to barcode RNA before cleanup and cDNA amplification. Libraries were
prepared with the Chromium Single Cell 3' Reagent Version 1 Kit. Each sample
was sequenced on 2 (Batch 1) or 1 (Batch 2) lanes of the HiSeq2500 (Illumina) in
Rapid Run Mode with paired-end sequencing parameters: Read1, 98 cycles; Index1,
14 cycles; Index2, 8 cycles; and Read2, 10 cycles.
The CD140a-depleted E12.5, E14.5, and E17.5 datasets and Fev-Cre;
ROSA26mTmG dataset in Figs. 5 and 7 were generated with Chromium Single Cell 3'
Reagent Version 2 kits (10X Genomics). In total, 27,000 cells were loaded onto
their respective wells and underwent the same processing as the Version 1 kits,
according to manufacturer instructions for Version 2 kits. Libraries were sequenced
on the NovaSeq (Illumina) with the same sequencing parameters as above.
Single-cell analysis. For the v1 datasets, we utilized CellRanger v1.1.0 software
for v1 datasets and v2.1.0 for v2 datasets with default settings for de-multi-
plexing, aligning reads to the mouse genome (10X Genomics pre-built mm10
reference genome) with STAR75 and counting unique molecular identifiers
(UMIs) to build transcriptomic profiles of individual cells. For the v1 datasets,
gene-barcode matrices were analyzed with the R package Seurat v1.4, using the
Fig. 6 Differentiated hormone+ endocrine cells transit through a Fev-expressing stage during pancreatic development. a–e Dual IF (for membrane GFP) and
fluorescent ISH for hormones in Fev-Cre; ROSA26mTmG lineage-traced animals at E14.5. n= 46 cells of 4 pancreata for Ins1 (100% labeled-lineage); n= 103
of 4 pancreata cells for Gcg (100% lineage-labeled); n= 6 cells of 2 pancreata for Sst (100% lineage-labeled); n= 26 cells of 2 pancreata for Ghrl/Gcg
(23.2% lineage-labeled); n= 71 cells of 8 pancreata for Ppy (90.1% lineage labeled). Scale bar represents 10 µm. f Schematic of E14.5 Fev-Cre; ROSA26mTmG
FACS sorting and single-cell RNA sequencing. g Representative FACS plots of sorted single, live GFP+ and TdTomato+/GFP− cells from dissociated
pancreata used for single-cell sequencing. h t-SNE visualization of endocrine cells in Fev-lineage-traced E14.5 mouse pancreata (n= 3). i Expression of
major markers of endocrine cell types. Color indicates level of expression, except for the eGFP plot, which indicates presence or absence of eGFP counts
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online tutorial as a guide7,76. We first performed a filtering step, retaining only
the cells that expressed a minimum of 200 genes and only the genes that were
expressed in at least 3 cells. A large number of cells did not meet this threshold
in the E17.5 time point and were determined to be red blood cells by the high
expression of hemoglobin genes. Variable genes were determined by mean-
variance relationship to identify highly expressed and variable genes with the
Seurat function MeanVarPlot with default settings. UMI counts were log-
normalized, and linear regression was performed with RegressOut to account for
differences in the number of UMIs between cells. PCA was then utilized to
determine sources of variability in the dataset with PCAfast. Significant PCs
were determined based on the Scree plot and utilized for Seurat’s graph-based
clustering algorithm (function FindClusters) with default parameters, except for
the resolution parameter. To vary cluster numbers, the resolution parameter in
FindClusters was adjusted from 0.6 to 3.0, and resulting clusters analyzed as
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follows. Clusters were visualized by t-SNE with Seurat’s RunTSNE function
using default settings77. Differentially expressed genes were determined with the
FindAllMarkers function, which uses a bimodal likelihood ratio test8. We con-
firmed differential gene-expression analysis with the Wilcoxon rank sum test
and Model-based Analysis of Single-cell Transcriptomics (MAST)9 utilizing
Seurat v2’s FindMarkers function with default settings. These tests calculate
adjusted p values for multiple comparisons. To determine the final number of
clusters, clusters were required to have at least nine significantly (p < 0.05) dif-
ferentially expressed genes with a twofold difference in expression in comparison
to all other clusters. Clusters were manually curated for differential gene
expression, and those that did not meet this threshold were manually merged
with the nearest cluster based on the phylogenetic tree from Seurat’s Build-
ClusterTree. In some cases, clusters met the nine-gene threshold but appeared to
have very similar differentially expressed genes to another cluster. This is likely a
result of the comparison of individual clusters against all other clusters in
determining differentially expressed genes. In these cases, a pairwise comparison
between the two clusters was performed and the same nine-gene threshold
applied. An exception to the nine-gene threshold was made to annotate the
proliferating population in early stages of the cell cycle within the E14.5
mesenchymal analysis (Fig. 4, cluster 8). Additionally, cluster 10 in the E14.5
mesenchymal dataset did not meet the nine-gene threshold. Rather, clusters 1–9
had distinct transcriptomic signatures (with at least nine differentially expressed
genes) that distinguished them from cluster 10. Lists of at least two-fold dif-
ferentially expressed genes for individual analyses are provided in Supplemen-
tary Data 2.
For v2 datasets, Seurat v2.2 and v2.3 was utilizing to perform the analysis. Cells
with fewer than 200 genes and genes expressed in fewer than 3 cells were removed,
as above. UMI counts were normalized with NormalizeData using default settings.
Variable genes were determined with FindVariableGenes, using the following cut-
offs suggested by the online tutorial (x.low.cutoff= 0.0125, x.high.cutoff= 3, and y.
cutoff= 0.5). Data were scaled and UMI counts regressed out with the ScaleData
function. PCA was performed with RunPCA, and significant PCs determined based
on the Scree plot. t-SNE analysis and clustering was performed as described above
for the v1 datasets. For the E12.5 exocrine dataset, the ductal population did not
meet the nine-gene threshold. All other populations within this dataset could be
distinguished from the ductal population by at least nine differentially expressed
genes, therefore we still annotated this cluster. Some of the clusters depicted for the
Fev-Cre; ROSA26mTmG dataset do not meet the nine-gene threshold. We chose to
visualize these clusters in order to better illustrate their placement along the
pseudotime trajectory.
Custom genome build. The custom genome for alignment of reads to eGFP and
TdTomato sequences from the mTmG mouse line was created according to
instructions provided by 10X Genomics reference support (https://
support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/
advanced/references). eGFP and TdTomato sequences were concatenated to the
mm10-2.1.0 reference genome (FASTA file) provided by 10× Genomics. eGFP and
TdTomato annotations were then concatenated to the mm10 annotations (GTF
file) provided by 10X Genomics. The cellranger mkref command was then utilized
with the genome and annotations with eGFP and TdTomato, as described in the
above link.
Pathway analysis. Pathway analysis and calculation of associated p values were
performed using the ConsensusPathDB overrepresentation analysis for pathway-
based sets category (http://cpdb.molgen.mpg.de)78.
Aggregating E17.5 v2 datasets. E17.5 technical replicates from the v2 dataset
were aggregated with Cellranger v2.1, utilizing the aggr function with default set-
tings. The aggregated dataset was used for analysis and merging with the E12.5 and
E14.5 v2 datasets.
Subclustering and merging datasets. Subclustering was performed by isolating
clusters of interest with the Seurat function SubsetData and reanalyzing as
described above (identification of variable gene, regression, and determination of
significant PCs). Cells were classified as epithelial based on the expression of E-
cadherin (Cdh1) and other known epithelial population markers. Cells that were
Cdh1−, Vim+, and Collagen3a1 (Col3a1)+ were classified as mesenchymal.
Multiple batches were merged with the MergeSeurat function. The merged dataset
was reanalyzed as above, with batch included as a latent variable in the RegressOut
function. The v1 E14.5 batch 1 and batch 2 clusters were robust to the sampling
differences between batches as evidenced by the contribution of cells from both
batches to each cluster (Supplementary Fig. 2b). We found high correlation of cell
type proportion between batches in all populations except the exocrine compart-
ment (acinar and ductal) (Supplementary Fig. 2c), possibly due to technical chal-
lenges of pancreatic dissociation. Within each cluster, batch 1 cells correlated most
highly with those of batch 2 contained in the same cluster, indicating proper cluster
calling with the merged datasets (Supplementary Fig. 2d).
For v2 datasets (E12.5, E14.5, and E17.5), multiple canonical correlation
analysis (multiCCA) from Seurat v2.3 was utilized to merge the epithelial
datasets39. The top 1000 most highly variable genes that were variable in at least 2
datasets were used for the alignment, as recommended in the Seurat tutorial. The
shared correlation strength of each CC was measured with Seurat’s
MetageneBicorPlot, and those before the drop-off were used for alignment,
analogous to the Scree plot in choosing significant PCs. We then aligned the
datasets with AlignSubspace and ran an integrated t-SNE and clustering analysis, as
outlined in the Seurat tutorial. Clusters were required to have 9 significantly
differentially expressed genes as described above. Clusters with similar differentially
expressed genes were verified with pairwise comparisons to the most related
clusters (based on BuildClusterTree) and merged if they did not meet the pairwise
nine-gene threshold. The Beta 2 cluster in the v2 endocrine merged timecourse
data met the nine-gene threshold for two out of the three differential expression
tests (Bimodal likelihood ratio and Wilcoxon rank sum tests), but had only eight
differentially expressed genes for the MAST test.
Doublets were identified based on co-expression of two mutually exclusive
genes, such as both mesenchymal and epithelial genes, and removed from further
analysis. In the v2 datasets, rare cells (4 cells in E12.5 and 13 cells in E14.5
endocrine datasets) with high levels of hemoglobin gene expression were removed
from the analysis.
Downsampling analysis. To determine if the sequencing depth was sufficient for
calling clusters, downsampling analysis was performed for the v1 E14.5 batch 1
dataset. Reads were randomly downsampled from the 10x Cellranger bam file
output to a specified percentage, then grouped based on UMI to generate a count
profile for each cell. The number of genes with greater than 0 counts was then
calculated. UMI downsampling was performed with the SampleUMI function. A
new Seurat object was created with the downsampled matrix and reanalyzed as
above.
The number of UMIs/cell was downsampled from an average of 4600 UMIs/cell
in the full dataset to 200 UMIs/cell, and the median number of genes/cell and
clustering robustness was then calculated. Clustering robustness was determined as
the percentage of cells within the same cluster, with clusters required to maintain at
least nine genes with a twofold change in expression in comparison to all other
clusters. Within this dataset, robust clustering was maintained all the way down to
500 UMIs/cell, when the percentage of cells in the same cluster began to climb,
indicating collapsing of individual clusters. Both of these downsampling analyses
indicate that sufficient sequencing depth was reached.
Pseudotemporal ordering. We utilized Monocle 2.6.425 to order cells in pseu-
dotime based on their transcriptomic similarity. For v1 timecourse datasets, batch-
corrected values and variable genes from Seurat analysis were used as input, uti-
lizing the gaussianff expressionFamily, and clusters were projected onto the
minimum spanning tree after ordering.
Fig. 7 Identification of candidate regulators of beta and alpha cell fate decisions. a Pseudotime ordering of the endocrine cells at E14.5 depicted in Fig. 6h
yields a bifurcated tree in which the two main branches terminate in cells that highly express Ins1 (beta cell branch) or Gcg (alpha cell branch). b Heatmap
depicting the expression of genes along each branch, in pseudotime. An independent expression pattern is calculated across the entire pseudotime
trajectory for each branch. Therefore, the portion of the trajectory before the branch point is displayed for each branch separately. Genes are clustered
based on expression pattern across pseudotime; selected genes with differential expression along the branches are highlighted to the right. c Gene
expression plots depicting the kinetic trends along each branch. d–e Multiplexed fluorescent ISH for Fev, Gng12, and Islet1 (d) or Fev, Peg10, and Islet1 (e) in
lineage-traced E14.5 Ngn3-Cre; ROSA26mTmG pancreas. Arrowheads identify lineage-traced Fev+/Islet1− cells with Gng12 (d, teal gradient arrowheads) or
Peg10 (e, indigo gradient arrowheads) expression. fMultiplexed fluorescent ISH for Fev, Gng12, and Ins1. Teal arrowheads identify lineage-traced Ins1+ beta
cells that express Gng12. g Multiplexed fluorescent ISH for Fev, Peg10, and Gcg. Indigo arrowheads identify lineage-traced Gcg+ alpha cells that express
Peg10. h Model for FevHi (yellow) cell differentiation into distinct alpha or beta cells. Peg10 and Gng12 expression in FevHi cells may represent progenitors
pre-fated towards the alpha and beta lineages, respectively, during endocrine lineage allocation. d–g Scale bars represent 10 µm. Blue staining represents
DAPI-labeled nuclei. Colors of arrowheads match colors of cells represented in h
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For the Fev-lineage-traced dataset, UMI counts and variable genes from the
Seurat analysis were used as input, utilizing the negBinom expressionFamily. To
find genes differentially expressed across the branch point in the trajectory, we used
monocle’s internal BEAM analysis and selected genes with an FDR cutoff of 0.001.
Gene expression patterns were plotted with plot_genes_branched_heatmap and
plot_multiple_branches_pseudotime.
Code availability. Seurat and monocle R objects used for analysis are available,
along with scripts, at Figshare, https://doi.org/10.6084/m9.figshare.c.4158458.
Scripts are available at https://github.com/sneddonucsf/2018-Developmental-
single-cell-RNA-sequencing.
Data availability
RNA sequences for the single-cell RNA-sequencing analyses reported in this paper have
been deposited in the GEO database under accession code GSE101099. The authors
declare that all data supporting the findings of this study are available within the article
and its supplementary information files or from the corresponding author upon rea-
sonable request.
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